Mohammed Najeeb Al Hallak

Also affiliated with The Barbara Ann Karmanos Cancer Institute

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth”.

Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth

Cancers(2020)10.3390/cancers12030750

N/A

0DataRank · unranked

38 citations

Gabriel Mpilla, Rachel Sexton, Srikant Viswanadha, Kumar V. Penmetsa, Amro Aboukameel +10 more

Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs

Cancers(2021)10.3390/cancers13164161

N/A

0DataRank · unranked

31 citations

Mohammed Najeeb Al Hallak, Philip A. Philip, Asfar S. Azmi, Ramzi M. Mohammad, Yiwei Li

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)

Lung Cancer(2021)10.1016/j.lungcan.2021.08.010

N/A

0DataRank · unranked

15 citations

Mohammad Asad, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Ammar Sukari, Yasmine Baca +18 more

Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy

Advances in Radiation Oncology(2022)10.1016/j.adro.2022.101122

N/A

0DataRank · unranked

20 citations

Mandana Kamgar, Amro Aboukameel, Sahar F. Bannoura, Brian Y. Chung, Yiwei Li +7 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C mutant cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.26.477874

N/A

0DataRank · unranked

1 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0251

N/A

0DataRank · unranked

13 citations

Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura +15 more

Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.27.534309

N/A

0DataRank · unranked

3 citations

Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura +15 more

Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.18.572102

N/A

0DataRank · unranked

2 citations

Amro Aboukameel, Husain Yar Khan, Md. Hafiz Uddin, Hyejeong Jang, Eliza W. Beal +8 more

Data from Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers

(2023)10.1158/2767-9764.c.6550541

N/A

0DataRank · unranked

0 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth

Cancer Letters(2024)10.1016/j.canlet.2024.217275

N/A

0DataRank · unranked

6 citations

Amro Aboukameel, Husain Yar Khan, Md. Hafiz Uddin, Hyejeong Jang, Eliza W. Beal +13 more

Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0321

N/A

0DataRank · unranked

6 citations

Gregory Dyson, Jennifer R. Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani +16 more

XPO1 inhibition as a clinically viable strategy to enhance durability of response to KRAS G12D inhibitor in pancreatic ductal adenocarcinoma.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.4_suppl.736

N/A

0DataRank · unranked

0 citations

Husain Yar Khan, Amro Aboukameel, Sahar F. Bannoura, Khalil Choucair, Eliza W. Beal +9 more

Race and correlates of cancer cachexia in the Detroit Research on Cancer Survivors cohort.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.12094

N/A

0DataRank · unranked

0 citations

Julie J. Ruterbusch, Mohammed Najeeb Al Hallak, Ann G. Schwartz, D Ponce de Le n Pandolfi, Tara Baird +3 more

Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.21.689857

N/A

0DataRank · unranked

0 citations

Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F. Bannoura, Md. Hafiz Uddin, Adeeb A. Aboukameel +27 more